Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

wing shan intl - CHIZF

CHIZF

Close Chg Chg %
0.27 -0.05 -19.92%

Open Market

0.22

-0.05 (19.92%)

Volume: 11.00K

Last Updated:

May 4, 2026, 10:37 AM EDT

Trade Now

Company Overview: wing shan intl - CHIZF

CHIZF Key Data

Open

$0.22

 Day Range

0.22 - 0.22

52 Week Range

0.22 - 0.35

 Market Cap

$1.11B

Shares Outstanding

5.04B

 Public Float

3.35B

Beta

0.32

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

N/A

Yield

20.53%

 Dividend

$0.01

EX-DIVIDEND DATE

Jul 3, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

  

CHIZF Performance

No Data Available

CHIZF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About wing shan intl - CHIZF

China Traditional Chinese Medicine Holdings Co., Ltd. operates as an investment holding company, which engages in the research and development, production and sale of Chinese medicine and pharmaceutical products. It operates through the following segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. The Yi Fang segment manufactures and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction. The Tian Jiang segment offers Chinese medical related healthcare solutions. The Tong Ji Tang segment refers to the sales of a wide range of healthcare products. The Medi-World segment deals with TCM Healthcare Solutions. The company was founded on June 16, 1905 and is headquartered in Hong Kong.

CHIZF At a Glance

China Traditional Chinese Medicine Holdings Co. Ltd.
Emperor Group Centre
Hong Kong,
Phone 852-2854-3393 Revenue 2.05B
Industry Pharmaceuticals: Major Net Income -47,586,071.02
Sector Health Technology Employees 14,846
Fiscal Year-end 12 / 2026
View SEC Filings

CHIZF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.659
Price to Book Ratio 0.462
Price to Cash Flow Ratio 5.22
Enterprise Value to EBITDA 6.609
Enterprise Value to Sales 0.652
Total Debt to Enterprise Value 0.267

CHIZF Efficiency

Revenue/Employee 138,163.61
Income Per Employee -3,205.313
Receivables Turnover 1.65
Total Asset Turnover 0.435

CHIZF Liquidity

Current Ratio 2.29
Quick Ratio 1.81
Cash Ratio 0.666

CHIZF Profitability

Gross Margin 48.092
Operating Margin 2.197
Pretax Margin -2.496
Net Margin -2.32
Return on Assets -1.009
Return on Equity -1.631
Return on Total Capital -1.448
Return on Invested Capital -1.552

CHIZF Capital Structure

Total Debt to Total Equity 12.182
Total Debt to Total Capital 10.86
Total Debt to Total Assets 7.709
Long-Term Debt to Equity 1.271
Long-Term Debt to Total Capital 1.133
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Wing Shan Intl - CHIZF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.12B 2.56B 2.29B 2.05B
Sales Growth
-28.09% +20.41% -10.31% -10.59%
Cost of Goods Sold (COGS) incl D&A
1.06B 1.25B 1.20B 1.06B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
160.72M 155.73M 156.20M 157.34M
Depreciation
101.29M 99.35M 101.85M 102.78M
Amortization of Intangibles
59.43M 56.38M 54.35M 54.56M
COGS Growth
-5.79% +18.34% -3.71% -11.45%
Gross Income
1.07B 1.31B 1.09B 986.46M
Gross Income Growth
-41.72% +22.45% -16.61% -9.63%
Gross Profit Margin
+50.32% +51.18% +47.59% +48.09%
2022 2023 2024 2025 5-year trend
SG&A Expense
913.94M 1.14B 997.49M 941.39M
Research & Development
90.86M 96.77M 82.82M 71.15M
Other SG&A
823.07M 1.05B 914.68M 870.24M
SGA Growth
-36.27% +25.26% -12.87% -5.62%
Other Operating Expense
- - - -
-
Unusual Expense
27.10M 3.01M 64.57M 102.15M
EBIT after Unusual Expense
127.98M 161.20M 29.57M (57.08M)
Non Operating Income/Expense
30.07M 40.25M 17.06M 19.67M
Non-Operating Interest Income
9.99M 9.21M 6.62M 4.82M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
32.77M 28.09M 23.83M 13.79M
Interest Expense Growth
-4.80% -14.28% -15.16% -42.14%
Gross Interest Expense
32.77M 28.09M 23.83M 13.79M
Interest Capitalized
- - - -
-
Pretax Income
125.28M 173.36M 22.80M (51.20M)
Pretax Income Growth
-68.08% +38.38% -86.85% -324.59%
Pretax Margin
+5.90% +6.78% +0.99% -2.50%
Income Tax
17.73M (24.21M) 19.78M 12.50M
Income Tax - Current - Domestic
28.94M 39.23M 39.83M 30.90M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(11.22M) (63.44M) (20.05M) (18.40M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
107.04M 197.05M 2.89M (63.73M)
Minority Interest Expense
(6.46M) 15.65M (4.63M) (16.14M)
Net Income
113.50M 181.40M 7.51M (47.59M)
Net Income Growth
-62.13% +59.82% -95.86% -733.41%
Net Margin Growth
+5.34% +7.09% +0.33% -2.32%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
113.50M 181.40M 7.51M (47.59M)
Preferred Dividends
- - - -
-
Net Income Available to Common
113.50M 181.40M 7.51M (47.59M)
EPS (Basic)
0.0225 0.036 0.0015 -0.0094
EPS (Basic) Growth
-62.18% +60.00% -95.83% -726.67%
Basic Shares Outstanding
5.04B 5.04B 5.04B 5.04B
EPS (Diluted)
0.0225 0.036 0.0015 -0.0094
EPS (Diluted) Growth
-62.18% +60.00% -95.83% -726.67%
Diluted Shares Outstanding
5.04B 5.04B 5.04B 5.04B
EBITDA
315.80M 319.95M 250.35M 202.41M
EBITDA Growth
-40.34% +1.31% -21.75% -19.15%
EBITDA Margin
+14.87% +12.51% +10.91% +9.87%

Wing Shan Intl in the News